Abstract Library

Welcome to the open-access search for all ENETS abstracts presented at the Annual ENETS Conferences.

Everyone can browse the library to find basic information on abstracts. To get full access to each entry, you will be asked to log in to your myENETS account.

 

Please note:

Participants of the 2025 ENETS Conference enjoy full access to the 2025 conference digital resources through myENETS: the abstract booklet, e-posters and videos, slide decks of talks, the poster carousel, and more.

Log in to myENETS

ENETS Abstract Search

#831 Overall Survival (OS) as a Function of the Number of Therapeutic Lines in Patients with Well-Differentiated Pancreatic Neuroendocrine Tumors (WDpNET)

Introduction: At least 9 therapeutic options are now available for unresectable WDpNET patients. Whether all lines can be administrated before tumor or toxic-related deaths is currently unknown.

Conference: 11th Annual ENETSConcerence (2014)

Presenting Author:

Authors: Berdelou A, Malka D, Leboulleux S, Boige V, Chougnet C,

Keywords: pNets,

#313 Effect of Somatostatin Analogues in the Control of Tumor Growth in Patients with Metastatic Lung Carcinoid Tumors

Introduction: Antitumor effect of Somatostatin analogues has been poorly documented in metastatic typical or atypical lung carcinoid tumors (LCT).

Conference: 8th Annual ENETSConcerence (2011)

Presenting Author:

Authors: Fekih M, Baudin E, Ducreux M, Chougnet C, Leboulleux S,

Keywords: carcinoid tumor, neuroendocrine tumors, therapeutics, Somatostatin analogues, lung,

#282 Characteristics of Patients with Well-differentiated Metastatic Lung Neuroendocrine Tumors

Introduction: Characteristics of well-differentiated lung neuroendocrine tumors (WDLNET) are poorly characterized at the metastatic stage.

Conference: 8th Annual ENETSConcerence (2011)

Presenting Author:

Authors: Chougnet C, Guigay J, Borget I, Leboulleux S, Duvillard P,

Keywords: lung NET, metastases, somatostatin analog, somatostatin recpetor scintigraphy ,